Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase 3 1

Status

Terminated 2Withdrawn 1Completed 1

Sponsor Class

OTHER 20INDUSTRY 9NETWORK 4

Study Type

Interventional 4

Sponsor

Cancer Type

Sarcoma 1Genitourinary 1Breast 1

Conditions

Prostatic Neoplasms 1Osteosarcoma 1Neoplasm Metastasis 1Giant Cell Tumor of Bone 1Breast Neoplasms 1

Interventions

Cisplatin 118Radiotherapy 114Cyclophosphamide 93Paclitaxel 85Gemcitabine 74Carboplatin 68Filgrastim 60Doxorubicin 57Vincristine 56Etoposide 56Docetaxel 56Fluorouracil 51Cytarabine 41Prednisone 40Methotrexate 40Leucovorin 39Dexamethasone 37Capecitabine 36Irinotecan 35Rituximab 29Oxaliplatin 28Granulocyte Colony-Stimulating Factor 27Cetuximab 26Bevacizumab 26durvalumab 24Temozolomide 24Radiotherapy, Intensity-Modulated 24Peripheral Blood Stem Cell Transplantation 24Magnetic Resonance Spectroscopy 24Surgical Procedures, Operative 22

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 2 × NETWORK × Denosumab × Clear all
NCT03869762 2026-04-13

DICE

Cancer Trials Ireland

Phase 2 Terminated
7 enrolled
Genitourinary

Neoplasm Metastasis, Prostatic Neoplasms

NCT02470091 2024-01-22

Denosumab in Treating Patients With Recurrent or Refractory Osteosarcoma

Children's Oncology Group

Phase 2 Completed
56 enrolled 18 charts
Sarcoma

Osteosarcoma

NCT03620149 2021-01-06

REDUCE

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2 Terminated
2 enrolled

Giant Cell Tumor of Bone

NCT03532087 2020-01-18

PERIDENO

Borstkanker Onderzoek Groep

Phase 2 Withdrawn
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡